Arch Therapeutics, Inc. Contracts & Agreements

Form of Amendment No. 20 to the First 2022 Notes (Filed With SEC on November 4, 2024)

Form of Amendment No. 20 to the Second 2022 Notes (Filed With SEC on November 4, 2024)

Form of Amendment No. 15 to the Third 2022 Notes (Filed With SEC on November 4, 2024)

Form of Amendment No. 6 to the Fourth 2022 Notes (Filed With SEC on November 4, 2024)

Form of Amendment No. 4 to the First 2024 Notes (Filed With SEC on November 4, 2024)

Form of Amendment No. 19 to the First 2022 Notes (Filed With SEC on September 19, 2024)

Form of Amendment No. 19 to the Second 2022 Notes (Filed With SEC on September 19, 2024)

Form of Amendment No. 14 to the Third 2022 Notes (Filed With SEC on September 19, 2024)

Form of Amendment No. 5 to the Fourth 2022 Notes (Filed With SEC on September 19, 2024)

Form of Amendment No. 3 to the First 2024 Notes (Filed With SEC on September 19, 2024)

Form of Amendment No. 1 to Securities Purchase Agreement (Filed With SEC on September 19, 2024)

Form of Amendment No. 18 to the First 2022 Notes (Filed With SEC on August 16, 2024)

Form of Amendment No. 18 to the Second 2022 Notes (Filed With SEC on August 16, 2024)

Form of Amendment No. 13 to the Third 2022 Notes (Filed With SEC on August 16, 2024)

Form of Amendment No. 4 to the Fourth 2022 Notes (Filed With SEC on August 16, 2024)

Form of Amendment No. 2 to the First 2024 Notes (Filed With SEC on August 16, 2024)

Form of Amendment No. 17 to the First 2022 Notes (Filed With SEC on July 5, 2024)

Form of Amendment No. 17 to the Second 2022 Notes (Filed With SEC on July 5, 2024)

Form of Amendment No. 12 to the Third 2022 Notes (Filed With SEC on July 5, 2024)

Form of Amendment No. 3 to the Fourth 2022 Notes (Filed With SEC on July 5, 2024)

Form of Amendment No. 1 to the First 2024 Notes (Filed With SEC on July 5, 2024)

Form of Backstop Agreement (Filed With SEC on June 25, 2024)

Form of Amendment No. 1 to PIPE Securities Purchase Agreement (Filed With SEC on June 25, 2024)

Form of Amendment No. 1 to PIPE Registration Rights Agreement (Filed With SEC on June 25, 2024)

Form of Securities Purchase Agreement (Filed With SEC on May 21, 2024)

Form of 2024 First Note (Filed With SEC on May 21, 2024)

Form of Registration Rights Agreement (Filed With SEC on May 21, 2024)

Form of Security Agreement (Filed With SEC on May 21, 2024)

Form of IP Security Agreement (Filed With SEC on May 21, 2024)

Form of Amendment No. 1 to Third A&R Registration Rights Agreement (Filed With SEC on May 6, 2024)

Form of Amendment No. 4 to Registration Rights Agreement (Filed With SEC on May 6, 2024)

Form of Amendment No. 16 to the First Notes (Filed With SEC on May 6, 2024)

Form of Amendment No. 16 to the Second Notes (Filed With SEC on May 6, 2024)

Form of Amendment No. 11 to the Third Notes (Filed With SEC on May 6, 2024)

Form of Amendment No. 2 to the Fourth Notes (Filed With SEC on May 6, 2024)

Form of Fourth Warrant (Filed With SEC on March 18, 2024)

Form of Amendment No. 3 to Securities Purchase Agreement (Filed With SEC on March 18, 2024)

Form of Third A&R Registration Rights Agreement (Filed With SEC on March 18, 2024)

Form of Fourth Note (Filed With SEC on March 18, 2024)

Form of Amendment No. 15 to the First Notes (Filed With SEC on March 18, 2024)

Form of Amendment No. 15 to the Second Notes (Filed With SEC on March 18, 2024)

Form of Amendment No. 10 to the Third Notes (Filed With SEC on March 18, 2024)

Form of Amendment No. 1 to the Fourth Notes (Filed With SEC on March 18, 2024)

Form of Amendment No. 14 to the First Notes, dated January 5, 2024 (Filed With SEC on January 11, 2024)

Form of Amendment No. 14 to the Second Notes, dated January 5, 2024 (Filed With SEC on January 11, 2024)

Form of Amendment No. 9 to the Third Notes, dated January 5, 2024 (Filed With SEC on January 11, 2024)

Form of Amendment No. 13 to the First Notes, dated November 21, 2023 (Filed With SEC on November 22, 2023)

Form of Amendment No. 13 to the Second Notes, dated November 21, 2023 (Filed With SEC on November 22, 2023)

Form of Amendment No. 8 to the Third Notes, dated November 21, 2023 (Filed With SEC on November 22, 2023)

Form of Amendment No. 3 to Second A&R Registration Rights Agreement (Filed With SEC on November 22, 2023)

Form of Amendment No. 3 to the Bridge Registration Rights Agreement (Filed With SEC on November 22, 2023)

Form of Underwriting Agreement (Filed With SEC on November 9, 2023)

Form of Investor Warrant (Filed With SEC on November 9, 2023)

Form of Pre-Funded Warrant (Filed With SEC on November 9, 2023)

Form of PIPE Pre-Funded Warrant (Filed With SEC on November 9, 2023)

Form of PIPE Investor Warrant (Filed With SEC on November 9, 2023)

Form of PIPE Placement Agent Warrant (Filed With SEC on November 9, 2023)

Form of True-Up Pre-Funded Warrant (Filed With SEC on November 9, 2023)

Form of 2022 Note Conversion Pre-Funded Warrant (Filed With SEC on November 9, 2023)

Form of Uplist Conversion Warrant (Filed With SEC on November 9, 2023)

Form of Exchange Investor Warrant (Filed With SEC on November 9, 2023)

Form of Amendment No. 12 to First Notes (Filed With SEC on November 9, 2023)

Form of Amendment No. 12 to Second Notes (Filed With SEC on November 9, 2023)

Form of Amendment No. 7 to Third Notes (Filed With SEC on November 9, 2023)

Form of Amendment No. 2 to Second A&R Registration Rights Agreement (Filed With SEC on November 9, 2023)

Form of Amendment No. 2 to Securities Purchase Agreement (Filed With SEC on November 9, 2023)

Form of Amendment No. 2 to Registration Rights Agreement (Filed With SEC on November 9, 2023)

Form of PIPE Securities Purchase Agreement (Filed With SEC on November 9, 2023)

Form of PIPE Registration Rights Agreement (Filed With SEC on November 9, 2023)

PIPE Placement Agency Agreement (Filed With SEC on November 9, 2023)

Form of Bridge Lock-Up Agreement (Filed With SEC on November 9, 2023)

Form of Underwriting Agreement (Filed With SEC on October 5, 2023)

Form of Warrant Agency Agreement (Filed With SEC on October 5, 2023)

Form of Pre-Funded Warrant Agency Agreement (Filed With SEC on October 5, 2023)

Form of Investor Warrant (Filed With SEC on October 5, 2023)

Form of Underwriter Warrant (Filed With SEC on October 5, 2023)

Form of Pre-Funded Warrant (Filed With SEC on October 5, 2023)

Form of Amendment No. 11 to the First Notes, dated September 30, 2023 (Filed With SEC on October 4, 2023)

Form of Amendment No. 11 to the Second Notes, dated September 30, 2023 (Filed With SEC on October 4, 2023)

Form of Amendment No. 6 to the Third Notes, dated September 30, 2023 (Filed With SEC on October 4, 2023)

Form of Placement Agent Warrant (Filed With SEC on September 7, 2023)

Form of Amendment No. 10 to the First Notes, dated August 30, 2023 (Filed With SEC on September 6, 2023)

Form of Amendment No. 10 to the Second Notes, dated August 30, 2023 (Filed With SEC on September 6, 2023)

Form of Amendment No. 5 to the Third Notes, dated August 30, 2023 (Filed With SEC on September 6, 2023)

Form of Amendment No. 1ot the Second A&R Registration Rights Agreement (Filed With SEC on September 6, 2023)

Form of Amendment No. 1 to the SPA (Filed With SEC on September 6, 2023)

Form of Amendment No. 1 to the Registration Rights Agreement (Filed With SEC on September 6, 2023)

Arch Therapeutics, Inc. Amended and Restated 2023 Equity Incentive Plan (Filed With SEC on August 23, 2023)

Form of Pre-Funded Warrant (Filed With SEC on August 11, 2023)

Form of Common Warrant (Filed With SEC on August 11, 2023)

Form of Amendment No. 8 to the First Notes (Filed With SEC on August 11, 2023)

Form of Amendment No. 8 to the Second Notes (Filed With SEC on August 11, 2023)

Form of Amendment No. 3 to the Third Notes (Filed With SEC on August 11, 2023)

Form of Omnibus Amendment to Notes and Warrants (Filed With SEC on August 11, 2023)

Form of Securities Purchase Agreement dated July 7, 2023, by and among the Company and the signatories thereto (Filed With SEC on August 11, 2023)

Form of Registration Rights Agreement dated July 7, 2023, by and among the Company and the signatories thereto (Filed With SEC on August 11, 2023)

Form of Amendment No. 9 to the First Notes, dated July 31, 2023 (Filed With SEC on August 4, 2023)

Form of Amendment No. 9 to the Second Notes, dated July 31, 2023 (Filed With SEC on August 4, 2023)

Form of Amendment No. 4 to the Third Notes, dated July 31, 2023 (Filed With SEC on August 4, 2023)

Arch Therapeutics, Inc. 2023 Equity Incentive Plan (Filed With SEC on July 24, 2023)

Form of Amendment No. 7 to the First Notes, dated July 1, 2023 (Filed With SEC on July 7, 2023)

Form of Amendment No. 7 to the Second Notes, dated July 1, 2023 (Filed With SEC on July 7, 2023)

Form of Amendment No. 2 to the Third Notes, dated July 1, 2023 (Filed With SEC on July 7, 2023)

Form of Amendment No. 6 to the First Notes, dated June 15, 2023 (Filed With SEC on June 22, 2023)

Form of Amendment No. 6 to the Second Notes, dated June 15, 2023 (Filed With SEC on June 22, 2023)

Form of Amendment No. 1 to the Third Notes, dated June 15, 2023 (Filed With SEC on June 22, 2023)

Form of Amendment No.2 to Securities Purchase Agreement (Filed With SEC on May 23, 2023)

Form of ThirdNote (Filed With SEC on May 23, 2023)

Form of Third Warrant (Filed With SEC on May 23, 2023)

Form of Second A&R Registration Rights Agreement (Filed With SEC on May 23, 2023)

Form of Amendment No. 5 to the First Notes (Filed With SEC on May 23, 2023)

Form of Amendment No. 5 to the Second Notes (Filed With SEC on May 23, 2023)

Form of Amendment No. 4 to the First Notes, dated April 15, 2023 (Filed With SEC on April 20, 2023)

Form of Amendment No. 4 to the Second Notes, dated April 15, 2023 (Filed With SEC on April 20, 2023)

Form of Amendment No. 1 to the A&R Registration Rights Agreement (Filed With SEC on April 20, 2023)

Form of Exchange Agreement, dated March 10, 2023 (Filed With SEC on March 17, 2023)

Form of Amendment No. 2 to the First Notes, dated March 10, 2023 (Filed With SEC on March 17, 2023)

Form of Amendment No. 2 to the Second Notes, dated March 10, 2023 (Filed With SEC on March 17, 2023)

Form of Amendment No. 3 to the First Notes, dated March 15, 2023 (Filed With SEC on March 17, 2023)

Form of Amendment No. 3 to the Second Notes, dated March 15, 2023 (Filed With SEC on March 17, 2023)

Form of Amendment No. 1 to Series 1 Notes, dated March 10, 2023 (Filed With SEC on March 17, 2023)

Form of Amendment No. 1 to Series 2 Notes, dated March 10, 2023 (Filed With SEC on March 17, 2023)

Form of First Notes Amendment (Filed With SEC on February 16, 2023)

Form of Second Notes Amendment (Filed With SEC on February 16, 2023)

Form of Warrant Agent Agreement (Filed With SEC on January 31, 2023)

Form of Investor Warrant (Filed With SEC on January 31, 2023)

Form of Underwriting Agreement (Filed With SEC on January 23, 2023)

Form of Investor Warrant (Filed With SEC on January 23, 2023)

Form of Underwriter Warrant (Filed With SEC on January 23, 2023)

Form of Amendment No.1 to Securities Purchase Agreement (Filed With SEC on January 20, 2023)

Form of Second Note (Filed With SEC on January 20, 2023)

Form of Second Warrant (Filed With SEC on January 20, 2023)

Form of A&R Registration Rights Agreement (Filed With SEC on January 20, 2023)

Form of Securities Purchase Agreement (Filed With SEC on July 8, 2022)

Form of 2022 Notes (Filed With SEC on July 8, 2022)

Form of 2022 Warrant (Filed With SEC on July 8, 2022)

Form of Registration Rights Agreement (Filed With SEC on July 8, 2022)

Form of Security Agreement (Filed With SEC on July 8, 2022)

Description of Securities (Filed With SEC on December 17, 2021)

Employment Agreement, effective June 30, 2021, by and between Arch Therapeutics, Inc. and Dan M. Yrigoyen (Filed With SEC on August 11, 2021)

First Amendment to Employment Agreement, effective August 9, 2021, by and between Arch Therapeutics, Inc. and Dan M. Yrigoyen (Filed With SEC on August 11, 2021)

Amendment No. 1 to Transition Agreement, dated December 31, 2020, by and between Arch Therapeutics, Inc. and Richard Davis (Filed With SEC on May 3, 2021)

Executive Employment Agreement, effective May 3, 2021, by and between Arch Therapeutics, Inc. and Michael S. Abrams (Filed With SEC on May 3, 2021)

Form of Securities Purchase Agreement (Filed With SEC on February 12, 2021)

Form of Series K Warrant (Filed With SEC on February 12, 2021)

Engagement Agreement (Filed With SEC on February 12, 2021)

Form of Placement Agent Warrant (Filed With SEC on February 12, 2021)

Form of Registration Rights Agreement (Filed With SEC on February 12, 2021)

Description of Securities (Filed With SEC on December 11, 2020)

Amendment to Series J Warrant to Purchase Common Stock (Filed With SEC on November 10, 2020)

Form of Convertible Notes (Filed With SEC on November 10, 2020)

Form of Amendment to Series D Warrants to Purchase Common Stock (Filed With SEC on June 5, 2020)

Form of Series J Warrant (Filed With SEC on June 5, 2020)

Form of Convertible Notes (Filed With SEC on June 5, 2020)

ARCH THERAPEUTICS, INC (Filed With SEC on April 27, 2020)

Form of Securities Purchase Agreement (Filed With SEC on October 18, 2019)

Form of Series I Warrants (Filed With SEC on October 18, 2019)

Engagement Agreement (Filed With SEC on October 18, 2019)

Form of Placement Agent Warrant (Filed With SEC on October 18, 2019)

Securities Purchase Agreement (Filed With SEC on May 13, 2019)

Form of Series H Warrants (Filed With SEC on May 13, 2019)

Advisory Agreement, effective July 19, 2018, by and between Arch Therapeutics, Inc. and Dr. Avtar Dhillon (Filed With SEC on July 20, 2018)

Offer Letter to Join the Board of Directors of Arch Therapeutics, Inc. dated July 19, 2018, by and between Arch Therapeutics, Inc. and Punit Dhillon (Filed With SEC on July 20, 2018)

Securities Purchase Agreement (Filed With SEC on June 29, 2018)

Form of Series G Warrants (Filed With SEC on June 29, 2018)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 21, 2017)

COMMON STOCK PURCHASE WARRANT Archtherapeutics, inc. (Filed With SEC on February 21, 2017)

AMENDMENT AGREEMENT TO ARCH THERAPEUTICS, INC. ACCELERATOR FUNDING AGREEMENT (Filed With SEC on September 29, 2016)

ARCHTHERaPEUTICS, INC. SeriesE Warrant To Purchase Common Stock (Filed With SEC on June 2, 2016)

SUBSCRIPTION AGREEMENT (Filed With SEC on June 2, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 2, 2016)

ARCH THERAPEUTICS,Inc. RESTRICTED STOCK BONUS AWARD AGREEMENT (Filed With SEC on May 6, 2016)

CONSULTING AGREEMENT (Filed With SEC on October 16, 2015)

SUBORDINATION AGREEMENT (Filed With SEC on September 9, 2015)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK)HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELYWITH... (Filed With SEC on August 7, 2015)

SEPARATION AGREEMENT (Filed With SEC on August 7, 2015)

ARCH THERAPEUTICS, INC. FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on July 31, 2015)

SUBSCRIPTION AGREEMENT (Filed With SEC on July 6, 2015)

ARCHTHERaPEUTICS, INC. SeriesD Warrant To Purchase Common Stock (Filed With SEC on July 6, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 6, 2015)

AMENDMENT TO SERIES A WARRANTS ANDSERIES C WARRANTS TO PURCHASE COMMON STOCK (Filed With SEC on June 23, 2015)

Exhibit 10.1 AMENDMENT TO SERIES C WARRANTS TO PURCHASECOMMON STOCK (Filed With SEC on June 1, 2015)

EXHIBIT 10.1 SUBSCRIPTION AGREEMENT (Filed With SEC on March 13, 2015)

Exhibit10.2 (Filed With SEC on March 13, 2015)

EXHIBIT 10.3 AMENDMENT TO SERIES C WARRANTS TO PURCHASECOMMON STOCK (Filed With SEC on March 13, 2015)

AMENDMENT TO SERIES A WARRANTS, SERIESB WARRANTS AND SERIES C WARRANTS TO PURCHASE COMMON STOCK (Filed With SEC on December 2, 2014)

ARCHTHERAPEUTICS, INC. ExecutiveEMPLOYMENT AGREEMENT (Filed With SEC on July 7, 2014)

SECURITIES TRANSFER AGREEMENT (Filed With SEC on May 5, 2014)

ARCH THERAPEUTICS, INC. FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 27, 2014)

[FORM OF SERIES A WARRANT] (Filed With SEC on January 31, 2014)

[FORM OF SERIES B WARRANT] (Filed With SEC on January 31, 2014)

[FORM OF SERIES C WARRANT] (Filed With SEC on January 31, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 31, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 31, 2014)

Massachusetts Life Sciences Center (MLSC) Life Sciences Accelerator Loan Program Solicitation No. 2013-ACC-1 Arch Therapeutics, Inc. Life Sciences Accelerator Funding Agreement (Filed With SEC on October 4, 2013)

SUBLEASE (Filed With SEC on October 4, 2013)

AmendmentNo. 1 to Agreement and Plan of Merger (Filed With SEC on August 14, 2013)

ARCHTHERAPEUTICS, INC. 2013 STOCK INCENTIVE PLAN NOTICEOF STOCK OPTION AWARD (Filed With SEC on August 14, 2013)

ARCH THERAPEUTICS,INC. 2013 STOCKINCENTIVE PLAN NOTICEOF Restricted Stock Unit AWARD (Filed With SEC on August 14, 2013)

ARCH THERAPEUTICS,INC. 2013 STOCK INCENTIVE PLAN NOTICEOF RESTRICTED STOCK Bonus AWARD (Filed With SEC on August 14, 2013)

ARCH THERAPEUTICS, INC. ExecutiveEMPLOYMENT AGREEMENT (Filed With SEC on July 8, 2013)

MASSACHUSETTS INSTITUTE OF TECHNOLOGY AND ARCH THERAPEUTICS, INC. AMENDED AND RESTATED EXCLUSIVE PATENTLICENSE AGREEMENT (Filed With SEC on June 26, 2013)

TERMINATION AGREEMENT AND RELEASE (Filed With SEC on June 26, 2013)

ARCH THERAPEUTICS, INC. ExecutiveEMPLOYMENT AGREEMENT (Filed With SEC on June 26, 2013)

ARCH THERAPEUTICS,INC. ExecutiveEMPLOYMENT AGREEMENT (Filed With SEC on June 26, 2013)

ARCH THERAPEUTICS, INC. 2013 STOCK INCENTIVE PLAN (Filed With SEC on June 24, 2013)

SECURITIES PURCHASE AGREEMENT (Signature Page) (Filed With SEC on May 20, 2013)

_____________________________________________________ AGREEMENT AND PLAN OF MERGER _____________________________________________________ BY AND AMONG ALMAH, INC. and ARCH... (Filed With SEC on May 13, 2013)

BINDINGLETTER OF INTENT (Filed With SEC on April 25, 2013)

PROMISSORYNOTE (Filed With SEC on April 25, 2013)

April19, 2013 FINANCINGAGREEMENT (Filed With SEC on April 25, 2013)

SECURITIES PURCHASE AGREEMENT (Signature Page) (Filed With SEC on April 25, 2013)

ALMAH, INC. A NEVADA CORPORATION (Filed With SEC on April 25, 2013)

Category

Industry

Companies

Contracts

Arch Therapeutics, Inc. Contracts & Agreements